Effects of Photobiomodulation on Insomnia in the Elderly: Clinical Trials of Phototherapy Devices
Key facts
- Who runs it
- China Medical University Hospital
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 60 people enrolled
- Started
- 26 Apr 2024
- Ended
- 3 Oct 2025
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Bright light
- Near-infrared light
- Bright light+ near-infrared light
- Record updated
- 2 December 2025
Who can take part
- Age
- 60 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Pittsburgh Sleep Quality Index score is 8 or above
- Early wakening ( 30 minutes before expected), or interruptted sleep for more than 30 minutes, lasting for more than 3 months
Who cannot take part
- Currently taking sedative-hypnotic drugs or receiving other non-drug treatments
- Movement disorder, inability to move independently
- Skin diseases, skin cancer, photosensitive skin diseases, or taking drugs that may cause photosensitivity (lithium salts, melatonin, antibiotics, A acid)
- Eye diseases such as glaucoma, diabetic retinopathy, and cataracts
- Bipolar disorder
- Light-induced epilepsy
- Sleep disorders such as sleep apnea and involuntary leg twitching
- Those who use cardiac rhythm regulators or artificial cardiopulmonary pacemakers
- Acute illness
- Infectious diseases
- Coagulation disorder
- Beck depression inventory-II score is greater than 13 points
- Abnormal blood pressure or fever
- Pregnancy and pregnant women
- Special physical abnormalities and sensory nerve abnormalities
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The study will recruit 60 participants aged 60 and above, who suffered from insomnia for at least 3 months. Sleep parameters and chronotypes assessed with questionnaires and actigraphy, daytime sleepiness, and biological rhythm (dim light melatonin onset) will be measured. The intervention involves light exposure using a prototype device developed by GCSOL Tech Co., Ltd., a company with expertise in light therapy research and development. Three conditions will be tested (1) bright light; (2) near-infrared light; (3) bright light+ near-infrared light. Data analysis will employ paired t-tests to compare sleep parameters and dim light melatonin onset before and after treatment. Kruskal-Wallis tests and multivariate linear regression will be used to examine differences between intervention groups, controlling for gender and age. Safety analysis will include monitoring adverse events.
The 3 groups in the trial
- Bright lightExisting treatment, for comparison
- Near-infrared lightExisting treatment, for comparison
- Bright light+ near-infrared lightExisting treatment, for comparison
Results explained
A paper that names this trial, explained in plain words.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Effects of bright light and near-infrared light on insomnia symptoms in community-dwelling older adults: a randomized clinical trial.Photodiagnosis and photodynamic therapy, 2026
- Record updated
- 2 December 2025